Brokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $39.14
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year […]
